News
Vaccinogen's New Anti-Cancer Vaccine Commercially Available in Europe This Year
Vaccinogen, Inc. announced that its new vaccine to block colon
cancer from recurring will be commercially available in Europe starting June 2008...
Learn more >>
Cancer Pioneer Reaches Key Agreement On Colon Cancer Drug OncoVAX®
Cancer research pioneer Michael G. Hanna Jr. Ph.D., also Vaccinogen, Inc.’s Founder, Chairman and CEO has acquired the rights to OncoVAX®...
Learn more >>
Publications
Human Vaccines 2006
Active Specific Immunotherapy with Autologous Tumor Cell Vaccines
Learn more >>
Cancer Vaccine Space
Vaccinogen is uniquely positioned within the cancer vaccine space
Learn more >>